top of page
DHA ARA Omega 3 palmitoylate oleoylate ether linked fatty acid Enriched Phosphatidylcholin

Welcome to Vitrupath Insight
The fermi surface for AI enabled deep value health information

the authorization code to access training documents = vitrupath

Supplemental, therapeutic, and clinical objectives

Item A = Assurance of the CDP ethanolamine pathway, PEMT, at between 30 and 40 percent of the capacity of the CDP Choline pathway.

Item B = Promoting of a background pH near, about or at pH 7.4.

Item C = CH2 methylene + e- from natural light or therapeutic light = excited CH2 enabling foundational polymerization of ribose in DNA, RNA, fatty Acids, Alkanes, e- carriers, NAD(H) and NADP(H), others also

Item D = Methylene cysteine (clinically known as HCY) lower than 6 or 7 um/L to about 3.7 um/L

Item E = counteract T M A O, diminishing what is the most or among the most indicative causal factor to sudden diminished outcome, sudden abated being and diminished behavior

Item F = An important detrimental metabolite, Methylene Cysteine, discovered in 1810, susceptible to therapy in 1878 or treatable since ancient eras, when found to be lower than 6 or 7 um/L, regardless of if being therapeutically caused to be lower than 6 or 7 um./L, results in a 500 to 1 decrease in abated being from all causes over a decade of observation among a population of about 10,000.  MEthylene cysteine was discovered in 1810, glycoolate in the 1840s or earlier and how to diminish levels of methylene cysteine to lower than 6 or 7 um/L were found in 1878, 1880 or 1882, 2 methylthetin, along with ancient exhibition of such capability as danshen, red sage or salvia m. 

Item G = The sigmoid graph used to ascertain risk for abated being by age used in particular industries since the 1800s is nearly precisely homologous to the change in average level of such detrimental metabolite by age.

Item H = Such detrimental metabolite, methylene cysteine, particularly above 6 or 7 um/L diminishes the neurological basis of social behavior and diminishes availability of PEMT produced oxytocin which is considered to be the molecular basis of group, community, and civilization level emotional and social affinity. Lower methylene cysteine to lower than 6 or 7 um/L prevents such a detrimental metabolite from removing electrons from tissues, prevents methylene cysteine from removing electrons from molecules and disables the ability of HCY to remove electrons carriers of (H2e1p)-. 

Item I = Such detrimental metabolite may be widely underprioritized, such that inpatient care to preemptively stabilize such metabolite such occur at 15 um/L regardless of symptoms, inpatient care should occur at 10 um/L when symptoms are exhibited, outpatient care to stabilize such detrimental factor should occur at 10 um/L if symptoms are not exhibited, outpatient care should occur if such detrimental factor is at 6 or 7 um/L with symptoms, and office visit, primary or other care should occur if such detrimental factor is at 6 or 7 um/L without symptoms. Therapeutic objective should be lower than 6 or 7 um/L toward about 3.7 um/L.

Item J = Institutes of Health advises use of choline metabolite supplementation in inpatient nutrition to prevent nosocomial risk and prevent systemic deterioration which can become primary cause of the most diminished of outcomes

Item K = A review of inpatient therapeutics and a review of outpatient therapeutics to a lower level, exhibits that these capabilities can increase levels of methylene cysteine including in the way that these factors are activated, metabolized and detoxified, requiring therapeutic capabilities to be implemented during most therapies. 

This site presents insight derived from information which should be reviewed with a health provider if being used in care. This information should be reviewed to be sure accuracy, specific applicability, relevance to conditions or relevance to circumstance. No warranties, express or otherwise, are provided. The information is provided as is. Copyrights and patents may apply to material presented. The information is exhibited to enhance solutioning, derivation of decisions and enhancing potential for optimal outcomes. All risk of use of this information is maintained by the user.

Minimal Daily Regimen

A, Enlyte or EnlyteRx(essential)

B, Lecithin with Vitamin K2(Essential)

C, grapeseed extract and probiotic such as align or leaky gut therapy(essential)

D, L arginine, L citrulline, L ornithine

E, Diverse Mineral Supplement with molybdenum, cobalt, iodide, calcium, vanadium(Essential)

F, Diverse Multi Vitamin with B12 Methylcobalamin, Vitamin K2 , Vitamin D, and Folate(Essential)

G, low intensity, short duration, exercise using resistance(essential)

H, EMF Protection Bedding, Clothing and Dwelling Protection (Power outlets, appliances and devices)(essential)

J, DHA docosahexaenoic Acid

K, ARA Arachidonic Acid at levels higher than DHA obtainment

L, Diverse Omega-3, Omega-6 and Omega-9 fatty acid or cholesterol supplement

M, Whole Animal Glandular, Micronized into fine granularity

N, Bone Powder

O, Sodium preferably as ancient pink Himalayan Sea Salt

Cognitive, Behavioral, Compulsion, Addiction

A, Interventional Ibogaine with magnesium or toxicity diminishment factor as clinically indicated

B, Agmatine, Lecithin, Vitamin k2, curcumin or an iNOS/NOS 2 inhibitor, emf protection

C, Narcan

D, typical therapies in these contexts, emerging therapies, Review complete daily regimen, Disease or Diminished Status Regimen, Simplified Factors Insight Version, Therapeutic API A, Therapeutic API B, Therapeutic API C, Foundational Document 1, Foundational Document 2, Foundational Document 3, Destabilizing Oncology Document, and the other documents in this compendium of research. 

Daily Regimen

A, EnlyteRx or Enlyte

B, Lecithin

C, Probiotic, Prebiotic, Olive Oil, Grapeseed Oil, Balsamic Vinegar, and Wide Coverage Antibiotic or 33 DMB during emergent circumstance, Align probiotic is useful, regularly administered laxative at least once every month or once every two months. 

​D,  Diverse mixed Vitamin Supplement with B12 Methylcobalamin, Folate, and 6s 5678 Tetrahydrofolate, Vitamin k2, Vitamin D

E, S Methyl Methionine Sulfonium or Gastromend HP

F, Diverse mixed Mineral Supplement that also has Molybdenum, Iodide, Cobalt, Calcium, and Vanadium

G, Plenty of Sodium as supplement or in food as ancient pink himalayan sea salt

H, Filtered Water filtered at point of obtainment or usage

I, EMF Protection, Bedding, Clothing and Dwelling Protection (Power outlets, appliances and devices)

J, Extended length Arachidonic Acid or Arachidonic Acid

K, L arginine, L citrulline, L ornithine, Agmatine, Spermidine, Spermine

J, Medium extent triglycerides, MCT

K, Branched extent Amino Acids

L, DHA Docosahexaenoic Acid

M, H2

​N, NMN, Niagen, NMR, Melatonin

O, DNA and RNA Nucleotides with Ethanolamine

P, Atmospheric particulate filter

Q, Low intensity, limited duration exercise using resistance.

​R, Berberine 

S, Curcumin

T, active hexose correlated compound AHCC

U, Nattokinase

V, Serrapeptase

W, Bone Powder

X, Whole animal glandular, micronized into fine granularity

Y, sodium adequacy, preferably as ancient pink Himalayan Sea Salt

Z, treatment for hyponatremia, even if marginally diagnosed

AHSA, specific or general oncology vaccines

AHSB, topical Geranyl choline

AHSC, Favipiravir and other antivirals

AHSD, Trikafta for conditions affecting CO2/O2 exchange

AHSE, Inhibition of HIF1 or HIF2 if involving prolonged nonresolution signaling because it can impair monocytes, erythrocytes, leukocytes, Leukocyte origin centers

AHSF, Green Tea, Moringa O or Moringa O Tea, Haddock Tea, Burdock Tea

AHSG, Olive Oil, Green Tea, Dark Chocolate, Moringa O Tea

AHSH, Humic Acid, Fulvic Acid, the product Blk Water 

AHSI, for radiation exposure Humic Acid, Fulvic Acid (Blk Water), Iodide, Phosphatidylcholine, choline

AHSJ, Review complete daily regimen, Disease or Diminished Status Regimen, Simplified Factors Insight Version, Therapeutic API A, Therapeutic API B, Therapeutic API C, Foundational Document 1, Foundational Document 2, Foundational Document 3, Destabilizing Oncology Document, and the other documents in this compendium of research. 

Counteracting Disease or Diminished Status Regimen

A, Daily Regimen

B, Active Hexose Correlated Compound

C, Se Methylselenocysteine, Methyl Selenic Acid, Methyl Selenol,  Sodium Selenite as Na2SeO3, Selenomethionine as C5H11NO2Se

​D,  Methylsulfonylmethane

E, Berberine

F, Curcumin

G, 2plamitoylphosphatidylcholine

H, Treatment for hyponatremia, low sodium and low Iodide, regardless of diagnosis and particularly with oncology

I, Nope 1

J, Nope 2 or other Nope metabolites include that with DHA, Oleoylate, Palmitate, extended length arachidonic acid, Omega-3 and ether linked fatty acid species

K, Topical Geranyl Choline

L, Topical Dimethylsulfide DMSO

M, Phage Therapy

N, Favipiravir or other Antiviral

O, Crispr Genetic Therapy

P, G Quadruplex Stabilization

Q, regenerate renal structure with Usag1 inhibition

R, regenerate cardiac complex with agrin grafts to matrix

S, regenerate dental structures by inhibiting Usag1 and increasing BMP7

T, stabilize renal conditions using inhibitors of CD20, GLP1 therapy and kidney stuff by golden standards

U, L arginine, L citrulline, L ornithine, Agmatine, Spermidine, Spermine

V, Nattokinase

W, Serapeptase

X, Sapropterin Tetrahydrobiopterin, Kuvan

Y, Inhibition of mitophagy or inhibition of autophagy to counteract pathology promoting exosomes

Z, Beneficial interventional therapy using therapeutic exosomes and secretegogues

AA, Retinol

ASB, All Trans Retinol

AC, Inhibiting Estrogen Receptor Alpha activation which harbors the PEMT inhibitor AP1

ASD, Causing dn DBC1 to become DBC1, but preventing DBC1 from integrating with SIRT1 but allowing DBC1 to complex with P53 to repress anerobic glycolysis the canonical disease status at cellular level. Pyst Protein can inhibit DBC1 among other factors to ascertain pocket characteristics for small molecule inhibitor ascertainment

ASF, Using Iodoacetate and another disease specific therapeutic

AG, Se Methylselenocysteine, Methyl Selenic Acid, Methyl Selenol,  Sodium Selenite as Na2SeO3, Selenomethionine as C5H11NO2Se

AH, Iron as Fe++ to promote ferroptosis, including with Se methylselenocysteine

AI, DHA docosahexaenoic Acid

AJ, ARA Arachidonic Acid at levels higher than DHA obtainment

AK, Diverse Omega-3, Omega-6 and Omega-9 fatty acid or cholesterol supplement

ASL, relocate to a region that does not use abated being as a sanction, counteracts a correlation

ASM, remove personal information and contact information from any database and information systems including internet systems and noninternet systems 

ASO, utilize only unscented, hypoallergenic beauty, cosmetic, hygeine, cleaning and environment cleaning products to conserve methyl groups

AHSP, specific or general oncology vaccines

AHSQ, topical Geranyl choline

AHSR, Favipiravir and other antivirals

AHSS, Trikafta for conditions affecting CO2/O2 exchange

AHST, Inhibition of HIF1 or HIF2 if involving prolonged nonresolution signaling because it can impair monocytes, erythrocytes, leukocytes, Leukocyte origin centers

AHSU, Trikafta for conditions involving O2/CO2 exchange

AHSV, Green Tea, Moringa O or Moringa O Tea, Haddock Tea, Burdock Tea

AHSW, Olive Oil, Green Tea, Dark Chocolate, Moringa O Tea

AHSX, Humic Acid, Fulvic Acid, the product Blk Water 

AHSY, for radiation exposure Humic Acid, Fulvic Acid (Blk Water), Iodide, Phosphatidylcholine, choline

AHSZ, typical therapies in these contexts, emerging therapies, Review complete daily regimen, Disease or Diminished Status Regimen, Simplified Factors Insight Version, Therapeutic API A, Therapeutic API B, Therapeutic API C, Foundational Document 1, Foundational Document 2, Foundational Document 3, Destabilizing Oncology Document, and the other documents in this compendium of research. 

Counteracting viral, microbial, oncology or insulin dysregulation statuses

A, Enlyte or EnlyteRx(essential)

B, Lecithin with Vitamin K2(Essential)

C, grapeseed extract and probiotic such as align or leaky gut therapy(essential)

D, L arginine, L citrulline, L ornithine

E, Diverse Mineral Supplement with molybdenum, cobalt, iodide, calcium, vanadium (before, after, but not during cytotoxic therapy)

F, Diverse Multi Vitamin with B12 Methylcobalamin, Vitamin K2 , Vitamin D, and Folate (before, after, but not during cytotoxic therapy)

G, low intensity, short duration, exercise using resistance(essential)

H, EMF Protection Bedding, Clothing and Dwelling Protection (Power outlets, appliances and devices)(essential)

J, DHA docosahexaenoic Acid

K, ARA Arachidonic Acid at levels higher than DHA obtainment

L, Diverse Omega-3, Omega-6 and Omega-9 fatty acid or cholesterol supplement

​J, Berberine 

K, Curcumin

L, active hexose correlated compound AHCC

M, Nattokinase

N, Serrapeptase

O, Retinol

P, All Trans Retinol

Q, Inhibiting Estrogen Receptor Alpha activation which harbors the PEMT inhibitor AP1

R, Causing dn DBC1 to stay as dn DBC1, or preventing DBC1 from integrating with SIRT1 but allowing DBC1 to complex with P53 to repress anerobic glycolysis the canonical disease status at cellular level. DBC1 displaces NAD+ from SIrt1 to exhibit a requisite freeing of (H2e1p)- that enables cellular division.

S, inhibiting availability of DBC1 for complexing with P53 if P53 is genetically impaired or if P53 is impaired only in the diseased cellular microenvironment. Inhibiting DBC1 because free DBC1 escapes Suv39H1 cellular senescence, histone methylation and genetic control programs.

T, Using Iodoacetate and another disease specific therapeutic to disrupt aerobic glycolysis or disrupted increase of glycolysis that counteracts P53 inhibition of glycolysis that occurs when PEMT is inhibited or which occurs in cellular level impairment

U, CART immunological therapy specific to disease phenotype

V, PD1 inhibitor, PDL1 inhibitor

W, Etopaside therapy and an inhibitor of SenP1 to cause cellular deterioration without requirement of P53, escaping potential P53 impairment and causing cellular deterioration in intricate essential mitotic phase mechanisms

X, topical geranyl choline

Y, phage therapy

Z, Se Methylselenocysteine, Methyl Selenic Acid, Methyl Selenol,  Sodium Selenite as Na2SeO3, Selenomethionine as C5H11NO2Se

AHSA, arginine, Citrulline, Ornithine, agmatine, putrescine, spermidine, spermine

AHSB, arginine, histidine, aspartate, glutame, cysteine, phosphoserine, Vitamin K2

AHSC, Iron as Fe++ to promote ferroptosis, including with Se methylselenocysteine

AHSD, Mitophagy Modulation Promotion or Inhibition

AHSE, Autophagy Modulation Promotion or Inhibition

AHSF, Choline kinase alpha inhibitor

AHSG, Proteasome inhibitor (26s, 20s or 19s)

IAHSH, inhibition of Bag1 with nutrient restriction

IAHSI, Inhibition of Bag1 and inhibition of Bag3. 

IAHSJ, Inhibition of SP1(counteracts latent viral disease) to reconstitute CD4+, reconstitued CD8+, inhibit PD1, inhibit PDL1 and disrupt SP1 escaping of diseased cellular entities from AP1 inhibition of telomerase in impaired cellular entities which would rapidly causes senescence if not counteracted by SP1 increasing of telomerase.

AHSK, Telomastatin inhibition of Telomerase

AHSL, Tissue specific ion channel inhibitors, oils, essences, derivatives and therapies

AHSM, S1P Lyase inhibitor

AHSN, S1P receptor Inhibitor

AHSO, GSK3B Inhibitor

AHSP, Deoxyribonucleotide, Ribonucleotide, Ethanolamine, Methylene, Uridine, therapy light or therapeutic light

AHSQ, Crispr genetic repair with biopsy phenotype or crispr genetic repair with known factor genetic repair

AHSR, iNOS/NOS 2 inhibitor, emf protection

AHSS, only obtain meat, chicken, eggs or fish if they are micronized or processed into fine granularity

AHST, relocate to a region that does not use abated being as a sanction, counteracts a correlation

AHSU, remove personal information and contact information from any database and information systems including internet systems and noninternet systems 

AHSV, utilize only unscented, hypoallergenic beauty, cosmetic, hygiene, cleaning and environment cleaning products to conserve methyl groups

AHSW, Interventional Somatostatin

AHSX, Trikafta for conditions involving O2/CO2 exchange

AHSY, Green Tea, Moringa O or Moringa O Tea, Haddock Tea, Burdock Tea

AHSZ, Olive Oil, Green Tea, Dark Chocolate, Moringa O Tea

AHSHSA, Humic Acid, Fulvic Acid, the product Blk Water 

AHSHSB, for radiation exposure Humic Acid, Fulvic Acid (Blk Water), Iodide, Phosphatidylcholine, choline

AHSHSC, typical therapies in these contexts, emerging therapies, Review complete daily regimen, Disease or Diminished Status Regimen, Simplified Factors Insight Version, Therapeutic API A, Therapeutic API B, Therapeutic API C, Foundational Document 1, Foundational Document 2, Foundational Document 3, Destabilizing Oncology Document, and the other documents in this compendium of research. 

​​​​​

​​​

Program Management, Development and Improvement

A, Remove abated being as a sanction. A moratorium that prevented abated being from being used as a sanction for a period of four years resulted in 20,000 decrease in abated being each year by the time the moratorium was concluded at year four, with a trend toward a likely 100,000 decrease by year 10 and a possible decrease of 1,000,000 by year 15. This trend was exhibited, also, in almost every other civilization.  This trend was accompanied by, at year four, a decrease in particularly detrimental interactions involving system workers to level exhibited two decades before. This trend was also accompanied by a 75 percent decrease in transportation mishaps, by year four.

B, Require methylene cysteine, tmao, and other primary indicators presented in this study to be prioritized in every instance of care and interventions involving diminished behavior or diminished outcomes otherwise.

C, Acknowledge the methylene csyteine and tmao deteriorate the neurological basis of social behavior and diminish the production of oxytocin by PEMT, resulting deterioration of human group, social emotional and other connections that enable human priority to be exhibited in behavioral outcomes and decisions.

D, Since 1906, when programs for inadequate housing and shelter emerged, enough resources have been allocated to temporary solutions that resumed homelessness once the program resources were deallocated, such that, instead, it would have been possible to build a home for every family in this civilization. There should be a requirement to begin constructing housing in such manner and with such priority, such that eventually eradication of homelessness might be achieved instead of allocating resources to a circumstance that has been caused to always be extant in diminished political, social and economic outcomes. 

E, There should be implemented a standard that prevents any system, process, scheme or circumstance that allow benefit to be obtained from the exhibition of diminished human outcomes. These should be replaced by remuneration that does not consider the volume of diminished outcomes.  Fee for service payment or fee for incident payment should not be implemented in any system or industry that is essential to assuring outcomes.  These might include reporting of monthly operational requirements including payment of workers along with a margin such as 5 percent similarly to the margins and rations afforded health coverage entities by the affordable care act.  These might include pay performance bundled with pay per individual schemes that may have pay for performance bonuses per incident but the foundation includes payment that is not per incident.

F, since a civilization with fiat currency can, at any time, print or allocate the economic resources eradicate their debt and doing so is only risky because prices may be increased in response or exchange rates may be increased in response, a civilization such print or produce enough financial resources to eradicate its debt while prohibiting exploitative increases of prices along with readiness to reset exchange rate valuation if there is detrimental response to such an action.  

G, civilizations should also print or produce enough financial resources to fund its systems each year or month directly instead of requiring schemes or circumstances that require exhibition of diminished outcomes in order for budgets and financial resources to be adequately available.  

H, since inflation is the only surely exhibited and most uncounteracted vector toward eventual destabilization of all civilizations, there should be a change to begin stabilizing prices, particularly of essential factors, along with intricate detailed justification of prices so that sources of destabilization can be ascertained and counteracted. 

I, A living wage should be established for every individual beginning at conception or beginning at verified conception.   

J, No system, or industry should maintain or exhibit any quota or objective that includes the exhibition of diminished outcomes to be achieved or satisfied. 

K, Every system, organization or nuance of civilization should produce a detailed explanation of why water from air technology to eradicate drought and permanent magnet energy which produces massive levels of energy without requirement of substrate or fuel and without production of population or output products, both are not being utilized. Any population of any region should be made aware of the exorbitant differences in costs and resources any such decision has made and is to cause in the future. 

L, Civilization level EMF protection of all EMF transporting wires, infrastructure, stations, devices, energy production stations, or other should occur, particularly incipiently including areas where diminished behavior and other diminished outcomes may be occurring with disparate increases. Dwellings and buildings should then be prioritized for EMF protection

M, populations should be made aware that since 1880, when ways of counteracting methylene cysteine emerged and when EMF emitting infrastructure then become installed into civilizations population centers, the factors presented here, in a particular civilization, might have resulted in what could be much more than 273,000,000 million instances of abated being which occurred before it would have otherwise or abated being which occurred in place of indefinitely sustainable being.  Misinformation and obfuscation, along with manipulation of sociopolitical process including causing or synthesizing events that redirect priority and focus of civilizations from assuring sustainable human outcomes, should not be utilized to cause populations to plan and implement their own untimely abated being. Because reproduction is a response to individual, group, social and environmental distress, including detrimental events, conditions in nature and, unfortunately, inadequately resolved human requirements, social requirements, behavioral requirements and physiological requirements in civilizations, the typical and misinformed usage of population control emerges not from reason, but emerges, instead, as way to avoid dispensing with the incipient reasons and impetuses for the synthesis of civilization. Some civilizations have had population levels that have been decreasing through much of modernity and some others have had population increases derived mostly from immigration while in some of these civilizations risk near completion of gestation might be at levels exhibited by undeveloped civilizations or exhibited by developing civilizations, and while maternal fertility rates have reach levels not ever observed since the emergence of such civilizations. Human populations perform as environmental scrubbing factors with factors produced by PEMT that are used to clean industrial wastes.

N, EMF has emerged as another way of causing inhibition of PEMT other than methylene cysteine, thereby sustaining levels of deterioration of sustainably optimal health and behavior. 

O, Assuring health includes prioritizing stable maintaining of a background pH near, about or at pH 7.4

P, Prioritization of therapy for and stabilization of leaky gut conditions are also essential to health and behavior

Q, stable civilizations require adequately paying system workers and assuring the welfare of systems workers. 

R, = The research performed in this compendium of research observed that most the major Human events, particularly regarding a particular civilization founded upon a declaration of the priority for Life, Liberty and Pursuit of happiness, have emerged in strong coordination with discoveries in lipid chemistry including the emerging of such civilization someone immediately after the discovery of what would become known as lecithin or mixed phospholipids including phosphatidylserine, phosphatidylethanolamine, phosphatidylinositol, phosphatidylcholine, choline and diverse enriching fatty acids. This foundation along with the influence DNA, RNA and physiology caused systems of civilizations to have such strong resemblance to physiology and biology that many esoteric findings in this research were observed incipiently, provided incipiently or confirmed by systems and systems workers before being confirmed conclusively in the research, often because the relevant research was obscure, esoteric, removed from publication and sometimes republished in esoteric media and sites.  These patterns are so important when exhibited in context of a civilization founded upon Life, Liberty and Pursuit of happiness that when a moratorium in 1972 was imposed to prevent use of abated being as a sanction in deliberations regarding diminished human outcomes, it causes particular detrimental acts to decrease to levels not observed since the 1950s, caused mishaps in a particular modality of transportation to decrease by 75%, caused a decrease of about 20,000 instances of abated being in that civilization and almost every other civilization in the world, that was a steepening trend that would have reached 100,000 annual decrease in that civilization at about 1 decade and possibly would have reached about 1,000,000 yearly decrease in abated being by 1.5 decades.  The moratorium was concluded in 1976. The work "Social Transformation of Medicine" ISBN 0465079350 and ISBN 9780465079353 presents this phenomenon as human events and outcomes increasingly becoming indicative of and revealing of inadequacies in systemic satisfaction of essential Human, social, behavioral and physiological requirements which result in deterioration of the neurological basis of social behavior and produce behavior programmed to resolve such inadequacy most completely, assuredly and readily. The research reviewed systems of all manner and observed a pervasive propensity for systems of the universes, correlative to their duration of exhibition, exhibit an inherent and sometimes necessary propensity to prioritize the system over other systems or other groups of systems, over the incipient circumstances of such system, over the perceived or incipient use of such system and a propensity to prioritize such system over Humanity, all of which must be managed intensively by civilizations. Thus, it was able to be conclusive derived that Humans were intended to conduct their being in community among one another in a way that makes disparities in outcomes observable, also able to be eluted into review, research, understanding, thoughtful resolution, prevention and in furtherance of reason, all in a way that adequately applies the unique known capabilities which humans have over other species and over inanimate material of the Universes.  Such furtherance of reason must include Human priority as its impetus and must adjudicatively emerge in furtherance of Human priority and reason.  So influential were the impetus of Life, Liberty and Pursuit of Happiness in such a civilization, and in other civilizations where such priorities emerged, that removal of the hindrances to being imposed by sanctions which impose abated being as a sanction caused a substantial and event strong increase in exhibition of resilient being.  Such impetuses Life, Liberty and Pursuit of Happiness, in strong correlation with the three methylations by PEMT of the open valences of the pnictogen nitrogen in the ethanolamine lead group of phosphatidylethanolamine, were so substantial that these seem to have influenced the synthesis of systems, behavior, artifacts and outcomes in a way that might have caused even diminished outcomes to exhibit such patterning inherently, in how such outcomes emerged, in why such outcomes emerged, and with regard to why such outcomes may have been inconsistent with reason, Human priority, a priority for Live, a priority for Liberty and inconsistent with a priority for allowed Pursuit of Happiness.  

​​​​

Fermi Image version recent new.jpg
bottom of page